CHU Liège - Hemato |
CEBPalpha mutation analysis
|
Dr Frédéric Lambert |
|
|
UZ Brussel - Molecular Hematology |
CEBPalpha mutation analysis
|
Marleen Bakkus/Christian Demanet |
|
|
AZ St-Jan Brugge - Laboratoriumgeneeskunde |
CEBPalpha mutation analysis
|
dr. Helena Devos/Friedel Nollet, Ph.D. |
|
|
UZ Gent |
CEBPalpha mutation analysis
|
Barbara Denys,
Karl Vandepoele |
|
|
UZ Leuven MolPLUZ |
CEBPalpha mutation analysis
|
Lucienne Michaux / Els Lierman |
|
|
CUB Erasme - Medical Genetics Dpt |
CEBPalpha mutation analysis
|
Pierre Heimann/Barbara Dessars/Hakim El Housni |
|
|
CHU Liège - Hemato |
CEBPalpha mutation analysis
|
Dr Frédéric LAMBERT |
|
|
AZ Delta |
CEBPalpha mutation analysis
|
Geert Martens, Elke Boone |
|
|
DNA PCR followed with Fragment analysis, direct sequencing confirmation for suspected mutant.
As described by Lin et al. Leukemia, 2006.